Stockreport

Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction

Masimo Corporation  (MASI) 
Last masimo corporation earnings: 4/28 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: masimo.com/about-masimo/investors
PDF With backing from leading healthcare investors, Clairity accelerates its mission to predict and prevent breast cancer and expand into cardiovascular disease BOSTON--( [Read more]